The above-mentioned research has unveiled the crucial roles of signaling pathways such as PI3K-AKT and PTEN-PI3K/AKT in the process, making the design of targeted drugs aiming to block or intervene in the migration of GC cells through these pathways a potential therapeutic strategy. This evidence concerns the gene PTEN and gastric cancer.